NKTX
Price
$2.50
Change
+$0.13 (+5.49%)
Updated
Dec 23 closing price
86 days until earnings call
ZYME
Price
$14.28
Change
+$0.14 (+0.99%)
Updated
Dec 23 closing price
Ad is loading...

NKTX vs ZYME

Header iconNKTX vs ZYME Comparison
Open Charts NKTX vs ZYMEBanner chart's image
Nkarta
Price$2.50
Change+$0.13 (+5.49%)
Volume$2.99M
CapitalizationN/A
Zymeworks
Price$14.28
Change+$0.14 (+0.99%)
Volume$665.67K
CapitalizationN/A
NKTX vs ZYME Comparison Chart
Loading...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NKTX vs. ZYME commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTX is a Hold and ZYME is a Buy.

Ad is loading...
COMPARISON
Comparison
Dec 24, 2024
Stock price -- (NKTX: $2.50 vs. ZYME: $14.28)
Brand notoriety: NKTX and ZYME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTX: 154% vs. ZYME: 124%
Market capitalization -- NKTX: $167.25M vs. ZYME: $983.57M
NKTX [@Biotechnology] is valued at $167.25M. ZYME’s [@Biotechnology] market capitalization is $983.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTX’s FA Score shows that 1 FA rating(s) are green whileZYME’s FA Score has 0 green FA rating(s).

  • NKTX’s FA Score: 1 green, 4 red.
  • ZYME’s FA Score: 0 green, 5 red.
According to our system of comparison, ZYME is a better buy in the long-term than NKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTX’s TA Score shows that 5 TA indicator(s) are bullish while ZYME’s TA Score has 6 bullish TA indicator(s).

  • NKTX’s TA Score: 5 bullish, 2 bearish.
  • ZYME’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NKTX is a better buy in the short-term than ZYME.

Price Growth

NKTX (@Biotechnology) experienced а +8.23% price change this week, while ZYME (@Biotechnology) price change was +3.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.03%. For the same industry, the average monthly price growth was -2.09%, and the average quarterly price growth was +3.05%.

Reported Earning Dates

NKTX is expected to report earnings on Mar 20, 2025.

ZYME is expected to report earnings on May 08, 2023.

Industries' Descriptions

@Biotechnology (-1.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZYME($984M) has a higher market cap than NKTX($167M). ZYME YTD gains are higher at: 37.440 vs. NKTX (-62.121). ZYME has higher annual earnings (EBITDA): -110.13M vs. NKTX (-119.34M). ZYME (297M) and NKTX (283M) have equal amount of cash in the bank . ZYME has less debt than NKTX: ZYME (20.2M) vs NKTX (85.4M). ZYME has higher revenues than NKTX: ZYME (62.2M) vs NKTX (0).
NKTXZYMENKTX / ZYME
Capitalization167M984M17%
EBITDA-119.34M-110.13M108%
Gain YTD-62.12137.440-166%
P/E RatioN/AN/A-
Revenue062.2M-
Total Cash283M297M95%
Total Debt85.4M20.2M423%
FUNDAMENTALS RATINGS
ZYME: Fundamental Ratings
ZYME
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
70
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NKTXZYME
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMFPX23.170.07
+0.30%
Principal MidCap S&P 400 Index R5
SFSLX25.590.06
+0.24%
1919 Financial Services C
APDJX17.310.03
+0.17%
Artisan International Small-Mid Advisor
IJSIX16.56N/A
N/A
VY® JPMorgan Small Cap Core Equity I
SVPSX86.50-0.07
-0.08%
ProFunds Small Cap Value Svc

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with PGEN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then PGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
+5.49%
PGEN - NKTX
50%
Loosely correlated
-2.16%
FATE - NKTX
49%
Loosely correlated
-1.19%
BCRX - NKTX
48%
Loosely correlated
+2.77%
IPSC - NKTX
48%
Loosely correlated
-7.27%
ALLO - NKTX
46%
Loosely correlated
+4.28%
More

ZYME and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZYME has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ZYME jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZYME
1D Price
Change %
ZYME100%
+0.99%
BEAM - ZYME
46%
Loosely correlated
-1.07%
NKTX - ZYME
42%
Loosely correlated
+5.49%
VRDN - ZYME
41%
Loosely correlated
+3.36%
INZY - ZYME
41%
Loosely correlated
+0.67%
ACLX - ZYME
41%
Loosely correlated
+1.65%
More